Arcturus Therapeutics Holdings Inc (ARCT)vsRevolution Medicines Inc (RVMD)
ARCT
Arcturus Therapeutics Holdings Inc
$7.30
-9.20%
HEALTHCARE · Cap: $220.85M
RVMD
Revolution Medicines Inc
$155.69
+4.02%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Arcturus Therapeutics Holdings Inc generates 7273% more annual revenue ($54.71M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -143.8%. ARCT earns a higher WallStSmart Score of 27/100 (F).
ARCT
Avoid27
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+78.2%
Fair Value
$33.91
Current Price
$7.30
$26.61 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -41.1% — below average capital efficiency
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ARCT
The strongest argument for ARCT centers on Price/Book, Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : ARCT
The primary concerns for ARCT are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
ARCT profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
ARCT carries more volatility with a beta of 2.42 — expect wider price swings.
ARCT is growing revenue faster at -93.0% — sustainability is the question.
ARCT generates stronger free cash flow (-19M), providing more financial flexibility.
Bottom Line
ARCT scores higher overall (27/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Arcturus Therapeutics Holdings Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. The company is headquartered in San Diego, California.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?